1. SBI-183

SBI-183 是一种具有口服活性的 QSOX1 抑制剂 (Kd: 20 μM)。SBI-183 可抑制肾癌细胞系、三阴性乳腺癌细胞系、肺腺癌细胞系和胰腺导管腺癌的增殖和侵袭表型。SBI-183 可体内抑制两种人肾细胞癌异种移植小鼠模型的肿瘤生长。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

SBI-183 Chemical Structure

SBI-183 Chemical Structure

CAS No. : 625403-59-0

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

SBI-183 is an orally active inhibitor of QSOX1 (Kd: 20 μM). SBI-183 suppresses the proliferative and invasive phenotype of renal cancer cell lines, including triple negative breast cancer cell line, lung adenocarcinoma cell line and pancreatic ductal adenocarcinoma. SBI-183 inhibits tumor growth in two human xenograft mouse models of renal cell carcinoma in vivo [1].

体外研究
(In Vitro)

SBI-183 (6.25-50 μmol/L, 15 min) 以剂量依赖性方式抑制 rQSOX1 的酶活[1]
SBI-183 可抑制肿瘤细胞的增殖,但不会杀死成纤维细胞或快速增殖的 PBMC (0.625-20 μmol/L, 5 days),抑制786-O、RCJ-41T2 和 MDA-MB-231的活力,IC50 分别为 4.6 μM、3.9 μM 和 2.4 μM (0.076 nM-40 μM, 72 h) [1]
SBI-183 (2.5-20 μM, 4-8 天)对 786-O、RCJ-41T2、MDA-MB-231、A549 和 MIA PaCa2 的二维和三维模型的肿瘤侵袭有剂量依赖性抑制作用[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Proliferation Assay[1]

Cell Line: 786-O, RCJ-41T2, MDA-MB-231, A549 和 MIA PaCa2
Concentration: 0.625, 1.25, 2.5, 5, 10, 20 μM
Incubation Time: 5 days
Result: Inhibited the growth of each tumor cell in a concentration-dependent manner.

Cell Invasion Assay[1]

Cell Line: 786-O, RCJ-41T2, MDA-MB-231, A549 和 MIA PaCa2
Concentration: 2.5, 5, 10, 20 μM
Incubation Time: 4, 6, 8 days
Result: Reduced invasion through Matrigel in each cell line.
体内研究
(In Vivo)

SBI-183 (786-O: 400 μg/小鼠/天,口服,35 天; RCJ-41T2: 100 mg/kg,口服,21 天) 可分别抑制两种肾细胞癌人异种移植小鼠模型的肿瘤生长[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Human xenograft mouse models of renal cell carcinoma (786-O and RCJ-41T2)[1]
Dosage: 400 μg/mouse/day (786-O); 100 mg/kg (RCJ-41T2)
Administration: Oral gavage (p.o.)
Result: Inhibited the growth of 786-O and RCJ-41T2 in vivo.
Reduced laminin-α4 deposition in RCJ-41T2 mouse xenografts.
分子量

296.36

Formula

C18H20N2O2

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献

SBI-183 相关分类

  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
SBI-183
目录号:
HY-165245
需求量: